2022-RA-1144-ESGO Management of immune-related adverse events in patients with solid tumours treated with dostarlimab in the GARNET study

Miscellaneous(2022)

引用 0|浏览5
暂无评分
关键词
dostarlimab,solid tumours,immune-related
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要